resources

Healthcare Global Enterprises Ltd.

NSE: HCG

BSE: 539787

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Hospital

642.60+8.1 (+1.28%)

9 Jul, 10:59 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Healthcare Global Enterprises Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	—
Quarterly Results	—	—	Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Jun Sept Dec	Mar
Conference Calls	—	—	—	—	—	—	17Aug 17Nov	16Feb 2Jun 18Aug 17Nov	16Feb 5Jun 19Aug 19Nov	6Mar 11Dec	13Feb 26May
Presentations	—	—	—	—	—	11Feb 17Jun 12Aug 11Nov	10Feb 26May 10Aug 27Sept 10Nov 29Nov	9Feb 25May 10Aug 9Nov	8Feb 28Jun 8Aug 9Nov	16Feb 24May 1Aug 12Nov 4Dec	5Feb 6Feb 19May

Corporate Announcements and Regulatory Filings

Healthcare Global Enterprises Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20183 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended June 30, 2026.
Closure of Trading Window30 Jun 2026
Closure of Trading Window
Intimation for closure of Trading Window under the SEBI (Prohibition of Insider Trading) Regulations, 2015, for the quarter ending June 30, 2026.
Diversification / Disinvestment29 Jun 2026
Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
Intimation regarding completion of divestment by the Company of its entire shareholding in BACC Health Care Private Limited, subsidiary of the Company, pursuant to the Share Purchase Agreement ....
Newspaper Publication13 Jun 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement in respect of Special Window for Transfer and Dematerialisation of Physical Securities of the Company.
Newspaper Publication9 Jun 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement of Postal Ballot Notice dated June 08, 2026, of the Company.
Postal Ballot8 Jun 2026
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Please find enclosed the copy of Postal Ballot Notice together with Explanatory Statement dated June 08, 2026.
Analyst / Investor Meet26 May 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Please see attached herewith the Transcript of the Earnings Call held on May 20, 2026, with Analysts/Investors to discuss the Audited Financial Results (both Standalone & Consolidated) ....
Resignation of Chief Financial Officer (CFO)25 May 2026
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Resignation of Interim CFO: Pursuant to the approval accorded by the Board of Directors at its meeting held on May 19, 2026, for the appointment of Mr. Sanjeev Kumar as the Chief Financial ....
Newspaper Publication21 May 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement of Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2026, approved at the meeting of Board of Directors ....
Reg.24(A)-Annual Secretarial Compliance20 May 2026
Compliances-Reg.24(A)-Annual Secretarial Compliance
Pursuant to Listing Regulations, please find enclosed herewith the Annual Secretarial Compliance Report of the Company for the financial year ended March 31, 2026, issued by M/s V Sreedharan ....
Analyst / Investor Meet20 May 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Further to our intimation dated May 07, 2026, we would like to inform you that the Audio recording of the Earnings Call with Analysts/Investors held on May 20, 2026, to discuss the Audited ....
Reg. 32 (1), (3) - Statement of Deviation & Variation20 May 2026
Statement Of Deviation Or Variation Of The Proceeds Of Rights Issue For The Quarter Ended March 31, 2026.
Statement of Deviation or Variation of the proceeds of Rights Issue for the quarter ended March 31, 2026.
Memorandum of Understanding /Agreements19 May 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
The Company has entered into a Share Purchase Agreement with Inviga Healthcare Fund I in relation to the divestment by way of sale of the entire equity shares held by the Company in BACC ....
Press Release / Media Release19 May 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press release on Annual Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2026.
General19 May 2026
Re-Appointment Of Internal Auditor Of The Company
The Board of Directors of the Company at their meeting held on May 19, 2026, has approved the re-appointment of Mr. Vijay S Shanbhag as the Internal Auditor of the Company under Section ....
Change in Management19 May 2026
Announcement under Regulation 30 (LODR)-Change in Management
The Board of Directors at their meeting held on May 19, 2026, has approved the appointment of Mr. Ravi Gothwal as AVP- Investor Relations, who shall be classified as a Senior Management ....
Change in Management19 May 2026
Announcement under Regulation 30 (LODR)-Change in Management
The Board of Directors of the Company at their meeting held on May 19, 2026, has approved the appointment of Mr. Sanjeev Kumar as the Chief Financial Officer and Key Managerial Personnel ....
Change in Directorate19 May 2026
Announcement under Regulation 30 (LODR)-Change in Directorate
The Board of Directors of the Company approved the re-appointment of Mr. Rajiv Maliwal (DIN: 00869035) as a Non-Executive Independent Director of the Company for a second term of 5 consecutive ....
Diversification / Disinvestment19 May 2026
Announcement under Regulation 30 (LODR)-Diversification / Disinvestment
The Board of Directors of the Company has approved the divestment by way of sale of its entire equity shareholding in its wholly owned subsidiary- BACC Health Care Private Limited to Inviga ....
Outcome of Board Meeting19 May 2026
Board Meeting Outcome for Outcome Of The Board Meeting_19.05.2026
The Company has announced the Outcome of the Board meeting held on May 19, 2026, including approval of audited financial results of the Company for the quarter and year ended March 31, 2026.

Frequently Asked Questions

Where can I download the annual report of Healthcare Global Enterprises Ltd.?

Annual reports of Healthcare Global Enterprises Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Healthcare Global Enterprises Ltd.?

Quarterly earnings results and presentations of Healthcare Global Enterprises Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Healthcare Global Enterprises Ltd. publish earnings call transcripts?

Earnings call transcripts of Healthcare Global Enterprises Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Healthcare Global Enterprises Ltd.?

Investor presentations and annual day presentations of Healthcare Global Enterprises Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Healthcare Global Enterprises Ltd.?

Corporate announcements and regulatory filings of Healthcare Global Enterprises Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Healthcare Global Enterprises Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Healthcare Global Enterprises Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Healthcare Global Enterprises Ltd.?

The ISIN (International Securities Identification Number) of Healthcare Global Enterprises Ltd. is INE075I01017. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Healthcare Global Enterprises Ltd. listed?

Healthcare Global Enterprises Ltd. is listed on NSE and BSE. The NSE symbol is HCG and the BSE code is -.

Where can I find the shareholding pattern of Healthcare Global Enterprises Ltd.?

The quarterly shareholding pattern of Healthcare Global Enterprises Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Healthcare Global Enterprises Ltd. on Sharpely?

Share price data for Healthcare Global Enterprises Ltd. is updated as of 9 Jul 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.